REALM THERAPEUTICS PLC's ticker is RLM and the CUSIP is 75606L103. A total of 8 filers reported holding REALM THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $116,000 | – | 29,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 360,866 | $1,173,000 | 0.10% |
| Orbimed Advisors | 1,021,484 | $3,051,000 | 0.04% |
| UBS Group AG | 1,860 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |